Harbour Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Harbour Investments's IBB Position: Q1 2026 in Review
Harbour Investments increased its iShares Biotechnology ETF (IBB) stake by 20% in Q1 2026, buying an estimated $86.9K and bringing the position to 3,026 shares worth $511K. The position accounts for 0.01% of the portfolio, ranked #1049.
Harbour Investments first reported a position in IBB in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.57M in Q1 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Harbour Investments held 3,026 shares of iShares Biotechnology ETF worth $511K as of Q1 2026.
- Harbour Investments bought 508 iShares Biotechnology ETF shares in Q1 2026, an estimated $86.9K.
- iShares Biotechnology ETF made up 0.01% of Harbour Investments's portfolio in Q1 2026, its #1049 holding.
- Harbour Investments first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 20 quarters since.
- Harbour Investments's iShares Biotechnology ETF position peaked at $1.57M in Q1 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.